Italia markets closed

ILMN Jun 2024 80.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,2000-0,2200 (-52,38%)
Alla chiusura: 03:13PM EDT
Schermo intero
Chiusura precedente0,4200
Aperto0,2000
Denaro0,1000
Lettera0,5000
Prezzo d'esercizio80,00
Scadenza2024-06-21
Min-Max giorno0,2000 - 0,2000
Contratto - Min-MaxN/D
Volume1
Open Interest151
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera